Assyro AI

Orange Book product · Generic (ANDA)

FEBUXOSTAT

FEBUXOSTAT

Generic (ANDA)ANDA 205414TE ABRX HIKMA
View FEBUXOSTAT familyOpen on FDA Orange Book

At a glance

Oct 15, 2019

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Oct 15, 2019

    6 yr 9 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

FEBUXOSTAT

Strength

40MG

Dosage form

TABLET

Route

ORAL

TE code

AB

Application

ANDA 205414

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of FEBUXOSTAT

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo